Enveda Raises $311M to Advance Nature-Inspired AI Drug Development

Enveda has secured $311 million in funding, valuing the AI-driven biotech company at $2 billion. The company is advancing clinical trials for drugs targeting skin conditions and weight maintenance after discontinuing GLP-1 therapies.